Cresilon announces Vetigel international distribution agreement
Cresilon is a Brooklyn-based biotechnology company that develops, manufactures, and markets haemostatic medical devices
Cresilon has announced that it has reached an agreement with Veterinary Instrumentation (Vi), to distribute Vetigel in the UK and Europe.
The haemostatic gel is to be sold directly to veterinary surgeons in the UK and throughout Europe.
Based in the UK, Vi is part of the Covetrus animal health family of worldwide businesses.
Vetigel is a plant-based haemostatic gel that instantly stops and controls bleeding and is available online for UK veterinary surgeons.
In addition to the UK, Vetigel will be marketed and distributed to veterinary surgeons throughout Europe and many other countries through Vi’s global distribution network.
Matt Lewis, vice president of sales at Cresilon, said: “Our partnership with Veterinary Instrumentation will help us provide more veterinary surgeons with a revolutionary haemostatic gel that significantly improves the standard of care for pets and animals. Vetigel has been used by thousands of veterinarians thus far and helps veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes.”
Cresilon is a Brooklyn-based biotechnology company that develops, manufactures, and markets haemostatic medical devices.
